Comments

TG Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does TG Therapeutics (TGTX) operate in?

TG Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TGTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

TG Therapeutics (TGTX) Forecast

News Earnings TG Therapeutics (TGTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

TG Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:TGTX | Benzinga

Explore TG Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TGTX.

Open	$33.75
Close	-
Volume / Avg.	261.73K / 3.11M
Day Range	$33.56 - $34.26
52 Wk Range	15.16 - 46.48
Market Cap	$5.44B
P/E Ratio	136.96
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	19.04%
Days to Cover	10.51

Recent News

TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show

TG Therapeutics posts Q1 profit and nearly doubles revenue, driven by rising Briumvi sales and higher full-year guidance for 2025.

Vandana Singh

Crude Oil Falls Over 2%; ISM Services PMI Rises In April

Avi Kapoor

Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher

TG Therapeutics has broken an important resistance level. There is a good chance that they will continue to move higher.

Mark Putrino

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$33.75
Close	-
Volume / Avg.	261.73K / 3.11M
Day Range	$33.56 - $34.26
52 Wk Range	15.16 - 46.48
Market Cap	$5.44B
P/E Ratio	136.96
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	19.04%
Days to Cover	10.51

About TG Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on th...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy TG Therapeutics (TGTX) stock?

You can purchase shares of TG Therapeutics (NASDAQ:TGTX) through any online brokerage.

View our list of the best stock brokerages

Who are TG Therapeutics (TGTX) competitors?

Other companies in TG Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for TG Therapeutics (TGTX) stock?

TG Therapeutics has a consensus price target of $33.22.

What is the current price for TG Therapeutics (TGTX)?

The stock price for TG Therapeutics (NASDAQ: TGTX) is $34.24 last updated May 23, 2025 at 11:22 AM EDT.

Does TG Therapeutics (TGTX) pay a dividend?

There are no upcoming dividends for TG Therapeutics.

When is TG Therapeutics (NASDAQ:TGTX) reporting earnings?

TG Therapeutics’s Q2 earnings are confirmed for Tuesday, August 5, 2025.

Is TG Therapeutics (TGTX) going to split?

There is no upcoming split for TG Therapeutics.

What sector and industry does TG Therapeutics (TGTX) operate in?

TG Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.